Immediate Impact
2 from Science/Nature 50 standout
Citing Papers
Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care
2023 Standout
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele
2023 Standout
Works of S Tuengerthal being referenced
Assessment of Morphological MRI for Pulmonary Changes in Cystic Fibrosis (CF) Patients
2007
[Criteria for the evaluation of the activity of sarcoidosis by bronchoalveolar lavage and angiotensin converting enzyme in the serum].
1983
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| S Tuengerthal | 384 | 323 | 254 | 39 | 711 | |
| Julie Macey | 423 | 166 | 209 | 37 | 684 | |
| Khadija Sheikh | 366 | 368 | 264 | 51 | 795 | |
| Julius Renne | 303 | 217 | 191 | 33 | 632 | |
| Astrid Schmähl | 282 | 397 | 222 | 14 | 594 | |
| Paul Hughes | 243 | 234 | 365 | 40 | 742 | |
| Yasuhiko Kawakami | 334 | 261 | 125 | 41 | 647 | |
| Kyungsoo Bae | 336 | 315 | 93 | 67 | 720 | |
| Munemasa Okada | 215 | 276 | 79 | 67 | 755 | |
| Oyunbileg von Stackelberg | 395 | 261 | 47 | 38 | 796 | |
| Renuka Uppaluri | 632 | 236 | 101 | 14 | 837 |
All Works
Loading papers...